Interactions Between Central Monoaminergic Systems: Dopamine-serotonin

Overview

Journal J Neurol Neurosurg Psychiatry

Publisher BMJ Publishing Group

Specialties Neurology
Neurosurgery
Psychiatry

Date 1979 Dec 1

PMID 160445

Citations 4

Authors

G ROCCATAGLIATA

C Albano

L Cocito

M Maffini

Affiliations

Soon will be listed here.

Abstract

Concentration of dopamine and serotonin metabolites (HVA and 5-HIAA) in the CSF was evaluated before and after pharmacological treatment in 19 patients with different neuropsychiatric diseases. In every case a reciprocal modification of the two metabolites occurred after treatment. The result supports the hypothesis of a functional balance between the monoaminergic systems in the central nervous system.

Citing Articles

Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants.

Leung S, Croft R, Guille V, Scholes K, ONeill B, Phan K Psychopharmacology (Berl). 2009; 208(2):233-44.

PMID: 20012022 DOI: 10.1007/s00213-009-1723-0.

Biochemical assessment of antidepressive drugs.

Ghose K Br J Clin Pharmacol. 1980; 10(6):539-50.

PMID: 6110435 PMC: 1430224. DOI: 10.1111/j.1365-2125.1980.tb00508.x.

Different gradients for neurotransmitter metabolites and protein in horse cerebrospinal fluid.

Vaughn D, Smyth G Vet Res Commun. 1989; 13(6):413-9.

PMID: 2483597 DOI: 10.1007/BF00402561.

Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites.

Vaughn D, Smyth G, Whitmer W, Satjawatcharaphong C Vet Res Commun. 1989; 13(3):237-49.

PMID: 2476887 DOI: 10.1007/BF00142050.

References

Heal D, Green A, Boullin D, Grahame-Smith D . Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa. Psychopharmacology (Berl). 1976; 49(3):287-300. DOI: 10.1007/BF00426832. View

Hornykiewicz O . Neurohumoral interactions and basal ganglia function and dysfunction. Res Publ Assoc Res Nerv Ment Dis. 1976; 55:269-80. View

Green A, Youdim M, Grahame-Smith D . Quipazine: its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour. Neuropharmacology. 1976; 15(3):173-9. DOI: 10.1016/0028-3908(76)90026-5. View

STENGEL E . Classification of mental disorders. Bull World Health Organ. 1959; 21:601-63. PMC: 2537983. View

ROCCATAGLIATA G, Albano C, Besio G, Ivaldi E . [Choreic dyskinesia and GABA - pharmaco-clinical approach. Preliminary note]. Schweiz Arch Neurol Neurochir Psychiatr. 1978; 123(1):63-8. View

Carlsson A, Biswas B, Lindqvist M . Influence of GABA and GABA-like drugs on monoaminergic mechanisms. Adv Biochem Psychopharmacol. 1977; 16:471-5. View

ROOS B . Decrease in homovanillic acid as evidence for dopamine receptor stimulation by apomorphine in the neostriatum of the rat. J Pharm Pharmacol. 1969; 21(4):263-4. DOI: 10.1111/j.2042-7158.1969.tb08243.x. View

CORRODI H, Farnebo L, Fuxe K, Hamberger B, Ungerstedt U . ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors. Eur J Pharmacol. 1972; 20(2):195-204. DOI: 10.1016/0014-2999(72)90149-5. View

Korf J, van Praag H, Sebens J . Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid. Biochem Pharmacol. 1971; 20(3):659-68. DOI: 10.1016/0006-2952(71)90152-3. View

10.

Korf J, Ottema S, Van der Veen I . Fluorometric determination of homovanillic acid in biological material after isolation on Sephadex G-10. Anal Biochem. 1971; 40(1):187-91. DOI: 10.1016/0003-2697(71)90091-1. View

11.

Goodwin F, Post R . Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis. Res Publ Assoc Res Nerv Ment Dis. 1975; 54:299-332. View